Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02067390 · ClinicalTrials.gov registry record
Urinary KIM-1 After Vancomycin or Linezolid Administration
A clinical trial, sponsored by Midwestern University.
- Terminated
- Registry status
- 5
- Enrollment target
NCT02067390 is a clinical trial that was terminated before completion, run by Midwestern University. The registered enrollment target is 5 participants.
The verdict
NCT02067390 was terminated before completion, sponsored by Midwestern University.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Acute renal injury is a common complication of critical illness. Drug induced renal insult compounds the degree of injury in many patients, and a great deal of research has focused on prevention of this complication. Traditional biomarkers of renal injury like serum creatinine and blood urea nitrogen content fail to consistently predict harm among patients at risk. Kidney Injury Molecule 1 (KIM-1) will be studied as a biomarker of renal injury.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-09 |
| Est. Completion | 2019-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02067390
The ClinicalTrials.gov registry entry for NCT02067390 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwestern University, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02067390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02067390 about?
NCT02067390 is a clinical study titled "Urinary KIM-1 After Vancomycin or Linezolid Administration". Acute renal injury is a common complication of critical illness. Drug induced renal insult compounds the degree of injury in many patients, and a great deal of research has focused on prevention of this complication. Traditional biomarkers of renal injury like serum creatinine and blood urea nitroge...
What is the current status of trial NCT02067390?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2013-09. Estimated completion is 2019-05.
Who is sponsoring clinical trial NCT02067390?
This trial is sponsored by Midwestern University, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.